This drug is a bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Our vision to excel and establish a strong foothold in the market has assisted us to evolve as a prominent organization engaged in offering Erythromycin Phosphate. This drug inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erythromycin Phosphate acts by penetrating the bacterial cell membrane. We offer this drug at affordable prices to clients.